Lee Brian Baker - SVP Finance and Admin., Turning Point Therapeutics, Inc
As of March 24, 2021
What is Lee Brian Baker's Net Worth?
The current estimated net worth of Turning Point Therapeutics, Inc's SVP Finance and Admin., Lee Brian Baker, is estimated to be about $6.91M . Lee Brian Baker owns about 4,116 units of Turning Point Therapeutics, Inc common stock. In the last 2 years at Turning Point Therapeutics, Inc, Lee Brian Baker has sold an estimated value of $6.68M worth.
What is Lee Brian Baker's Past Insider Trading?
Lee Brian Baker's largest purchase order was 28,438 units , worth over $132.92K on January 8, 2021. Lee Brian Baker's largest sale order was 31,238 units , worth over $3.82M on January 8, 2021. In total, Lee Brian Baker has made about 5 transactions over 2 years of their time at Turning Point Therapeutics, Inc. Lee Brian Baker usually trades in January, with the busiest year in 2021. The most recent transaction was a sale order of 28,435 units , worth over $2.86M on March 24, 2021.
Lee Brian Baker
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Lee Brian Baker's' Mailing Address?
- Mailing address is C/o Turning Point Therapeutics, Inc. 10628 Science Center Dr., Ste. 225 San Diego CA 92121 CA
Turning Point Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Athena Countouriotis, M.D. | 2020 | $580,000 | - | - | $14,131,423 | $539,400 | $11,400 | $15,262,223 |
| Athena Countouriotis, M.D. | 2018 | $329,442 | $400,000 | $ | $7,766,667 | $158,971 | $8,690 | $8,663,770 |
| Yi Larson | 2020 | $451,688 | - | - | $1,434,883 | $255,600 | $114,716 | $2,256,887 |
| Yi Larson | 2019 | $158,523 | $360,757 | - | $11,715,012 | $283,500 | $61,633 | $12,579,425 |
| Annette North | 2020 | $400,000 | - | - | $2,434,953 | $230,400 | $11,400 | $3,076,753 |
| Annette North | 2018 | $ | $ | $ | $ | $ | $ | $ |
| Andrew Partridge | 2020 | $220,758 | - | $1,288,710 | $5,210,033 | $304,560 | $202,500 | $7,226,561 |
| Andrew Partridge | 2018 | $ | $ | $ | $ | $ | $ | $ |
| Siegfried Reich, Ph.D. | 2020 | $325,000 | - | - | $5,227,485 | $187,097 | - | $5,739,582 |
| Siegfried Reich, Ph.D. | 2018 | $ | $ | $ | $ | $ | $ | $ |
| Jingrong Jean Cui, Ph.D. | 2020 | $43,217 | - | - | $1,870,156 | - | $1,189,061 | $3,102,434 |
| Jingrong Jean Cui, Ph.D. | 2018 | $399,289 | $ | $ | $11,715,012 | $283,500 | $3,674 | $12,401,475 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1595893/000119312521117723/d27986ddef14a.htm
What are Turning Point Therapeutics, Inc's Past Insider Trades?
Turning Point Therapeutics, Inc's most recent insider trade came on February 11, 2022 by Siegfried Reich who sold 397 units worth $14.41K . In the last 3 years, insiders at Turning Point Therapeutics, Inc have sold an estimated value of $71.81M and bought an estimated value of $66.53M worth of shares. Insider trading is most common in February, with the busiest year in 2020. The most active traders at the company are Jean Jingrong Cui, Director, Annette North, EVP & General Counsel, and Athena Countouriotis, President & CEO .
Turning Point Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||